The case revolves around the sale of Omega Pharma to the American pharmaceutical giant Perrigo in 2015. Perrigo paid 3.8 billion euros to take over the company, which was owned by Marc Coucke and the Dutch investment fund Waterland. But soon after the sale, Perrigo felt cheated and filed a claim of 1.9 billion because they felt that Coucke and Waterland had presented Omega Pharma’s business figure better in order to negotiate a higher sales price.
–
Related posts:
Tallink's Strong 2nd Quarter Results Indicate Dividend Renewal, Analysts Say
Rising Trend: 55% Increase in Sales of Used Cars in Latvia, Moller Auto Reveals
Chemours Factory Subsidy Controversy: Documents Released on Environmental and Health Issues
The Truth About the Cryptocurrency Market Rally and the Bitcoin ETF Approval
